1005-39-6

Basic information

• Product Name: 4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE
• Synonyms: 2-(Methylsulfanyl)-4,6-pyrimidinediamine;2-Methylthio-4,6-diaminopyrimidine;Pyrimidine, 4,6-diamino-2-(methylthio)-;4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE;AKOS USSH-4110074;AKOS BBS-00007356;6-AMINO-2-(METHYLTHIO)-4-PYRIMIDINYLAMINE;2-methylthiopyrimidine-4,6-diamine
• CAS NO: 1005-39-6
• Molecular Formula: C₅H₈N₄S
• Molecular Weight: 156.21
• EINECS: 213-735-9
• Mol File: 1005-39-6.mol

Chemical Properties

• Melting Point: 189-193 °C
• Boiling Point: 413.5 °C at 760 mmHg
• Flash Point: 203.9 °C
• Appearance: light yellow crystalline powder
• Density: 1.38 g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.671
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 5.15±0.10(Predicted)
• BRN: 127235
• CAS DataBase Reference: 4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE(1005-39-6)
• EPA Substance Registry System: 4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE(1005-39-6)

Safety Data

• Hazard Codes: Xn
• Statements: 36/37/38-22
• Safety Statements: 36/37/39-26
• RIDADR: 2811
• HazardClass: 6.1
• PackingGroup: III
• Hazardous Substances Data: 1005-39-6(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its reactivity with other compounds, such as 3-Ethoxy-acrylic acid ethyl ester, allows for the creation of new molecules with potential therapeutic applications.
Used in Chemical Research:
4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE is used as a research compound in the field of organic chemistry. Its unique properties and reactivity make it a valuable tool for studying chemical reactions and developing new synthetic methods.
Used in Material Science:
4,6-DIAMINO-2-METHYLMERCAPTOPYRIMIDINE can be used in the development of new materials with specific properties. Its ability to react with other compounds can lead to the creation of materials with unique characteristics, such as improved stability or enhanced reactivity.

InChI:InChI=1/C5H8N4S/c1-10-5-8-3(6)2-4(7)9-5/h2H,1H3,(H4,6,7,8,9)

Upstream product

• 1004-39-3 4,6-diaminopyrimidine-2(1H)-thione 
• 74-88-4 methyl iodide 
• 1005-38-5 4-amino-6-chloro-2-methylthiopyrimidine 
• 1004-39-3 4,6-diamino-2-mercaptopyrimidine 

Downstream Products

• 103853-50-5 N²-(4-chloro-phenyl)-pyrimidine-2,4,6-triyltriamine 
• 52222-43-2 2-(methylthio)-5-nitrosopyrimidine-4,6-diamine 
• 67-52-7 BARBITURIC ACID 
• 36707-42-3 diethyl 2-((6-amino-2-(methylthio)pyrimidin-4-ylamino)methylene)malonate 
• 36707-43-4 [(6-acetylamino-2-methylsulfanyl-pyrimidin-4-ylamino)-methylene]-malonic acid diethyl ester 
• 36707-44-5 4-acetylamino-2-methylsulfanyl-5-oxo-5,8-dihydro-pyrido[2,3-d]pyrimidine-6-carboxylic acid ethyl ester 
• 1309571-70-7 4-amino-2-(methylsulfanyl)-5-(3,4,5-trimethoxyphenyl)-5,9-dihydrofuro[3',4':5,6]pyrido[2,3-d]pyrimidin-6(8H)-one 
• 1309571-71-8 4-amino-5-(3,5-dibromophenyl)-2-(methylsulfanyl)-5,9-dihydrofuro[3',4':5,6]pyrido [2,3-d]pyrimidin-6(8H)-one 
• 959934-71-5 Ethyl 4-amino-5-(4-cyano-2-methoxyphenyl)-7-methyl-2-(methylthio)-5,8-dihydropyrido[2,3-d]-pyrimidine-6-carboxylate 
• 1431-40-9 2-methylsulfanyl-pyrimidine-4,5,6-triamine 
• 1198-83-0 2-(methylthio)-7H-purin-6-amine 
• 102712-28-7 4-(7-Amino-5-methylsulfanyl-[1,2,3]triazolo[4,5-d]pyrimidin-2-yl)-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide 

Relevant articles and documents

Imidazopyridine- and purine-thioacetamide derivatives: Potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1)

Nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) belongs to the family of ecto-nucleotidases, which control extracellular nucleotide, nucleoside, and (di)phosphate levels. To study the (patho)physiological roles of NPP1 potent and selective inhibitors with drug-like properties are required. Therefore, a compound library was screened for NPP1 inhibitors using a colorimetric assay with p-nitrophenyl 5′-thymidine monophosphate (p-Nph-5′-TMP) as an artificial substrate. This led to the discovery of 2-(3H-imidazo[4,5-b]pyridin-2-ylthio)-N-(3,4-dimethoxyphenyl)acetamide (5a) as a hit compound with a Ki value of 217 nM. Subsequent structure-activity relationship studies led to the development of purine and imidazo[4,5-b]pyridine analogues with high inhibitory potency (Ki values of 5.00 nM and 29.6 nM, respectively) when assayed with p-Nph-5′-TMP as a substrate. Surprisingly, the compounds were significantly less potent when tested versus ATP as a substrate, with Ki values in the low micromolar range. A prototypic inhibitor was investigated for its mechanism of inhibition and found to be competitive versus both substrates.

Synthesis, dihydrofolate reductase inhibition, anti-proliferative testing, and saturation transfer difference1H-NMR study of some new 2-substituted-4,6-diaminopyrimidine derivatives

A series of 2-substituted-4,6-diaminipyrimidine derivatives were synthesized and evaluated for their dihydrofolate reductase (DHFR) inhibitory activity. Saturation transfer difference (STD) 1H-NMR experiments were used to probe the binding char

Docking studies and development of novel 5-heteroarylamino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as potential antimalarials

MOE-Dock (Docking software) was used to predict the binding modes of 10 novel and potent 5-substituted amino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines (compounds I-X) as part of our antimalarial drug development programme. This was done by analyzing the interaction of these compounds with the active sites of 11 enzymes present in Plasmodium falciparum and based on this, effective binding was observed to enzyme P. falciparum glutathione reductase (PfGR). The binding scores for compounds I-X with PfGR were also congruent with their antimalarial activity. Three additional analogs were then designed and synthesized based on the above docking study and the pharmacophoric requirements for this class.